RStudio (Phil Bowsher) and Novartis (Matt Fidler) will be presenting a free workshop on R for Drug Development on Monday morning 10 June 2019 prior to the PAGE meeting in Stockholm, Sweden. This short course will provide a hands-on introduction to flexible and powerful tools for statistical analysis, reproducible research and interactive visualizations using Tidyverse, Shiny and R Markdown. No prior knowledge of R, RStudio or Shiny is needed. Additionally, immunogenicity assessments and other drug development examples will be reviewed. Modelling and simulation workflows using the nlmixr and RxODE packages will be integrated into the discussion. For more information and signing up please visit https://www.rstudio.com/workshops/page-workshop/; while the course is free, the number of seats is very limited and so registration is essential.
Those attending this course should also consider attending the dedicated one-day workshop on nonlinear mixed-effects model parameter estimation using nlmixr, , RxODE, shinyMixR, and xpose.nlmixr on Tuesday 11 June, for which an Rstudio instance will be provided! The workshop will consist of a mixture of lectures and hands-on exercises. Visit https://www.eventbrite.co.uk/e/nlmixr-workshop-tickets-55214293438 for registration. A nominal fee of €175 per participant covers the workshop room, lunch and coffee/tea. Best, Wenping Wang, PhD Executive Director, Pharmacometrics Novartis Pharmaceuticals Corporation One Health Plaza, East Hanover, NJ 07936-1080, USA Phone +1 862 7789009; Fax +1 9737818265
